Rigor Reviewed

Rigor-Reviewed Manuscript

Multifaceted Strategies for Hypertension Control in Low-Income Patients.

Name: Αlpha¹ Rigor Record — Multifaceted Strategies for Hypertension Control in Low-Income Patients.
Item: Multifaceted Strategies for Hypertension Control in Low-Income Patients.
Rating: 39
Author: Αlpha¹

Mills KT, Krousel-Wood M, Peacock EM, Chen J, Allouch F, Carreras AK, Geng S, Cyprian A, Davis G, Fuqua SR, Gilliam D, Greer A, Mitchell T, Gray-Winfrey W, Williams S, Wiltz GM, Winfrey KL, He H, Whelton PK, He J

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 1★ (Critical), 3 critical, 4 high issues for “Multifaceted Strategies for Hypertension Control in Low-Income Patients.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

1 / 5

Critical — a demonstrable failure

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

StatisticsImpossible or misreported statistic ×3−3★
IntegrityIntegrity concern ×2−1★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
StatisticsPrinted percentage does not match its own count (capped) ×3−0.25★
ReportingData & code availability partially met−0.25★

A demonstrable critical failure caps the rating at the minimum, regardless of the deductions above.

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

The numeric-impossibility checks (GRIM/GRIMMER/DEBIT/SPRITE) did not run: 4 reported means were read, and their group size is not stated where the values are printed (this source has no machine-readable table structure). These checks need the count the mean was averaged over, so none was performed.

Problems surfaced6 types

Numerical inconsistencies3

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Summary statistic impossible for the stated N (GRIM/GRIMMER)Recomputed
Printed percentage does not match its own countRecomputed
Internal contradictions in the reported numbersAssessed

Overstated conclusions2

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Conclusions only partially backed by the presented evidenceAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

Critical findings

• PERCENT: 73.4% does not match the reported count 468/642
• PERCENT: 44% does not match the reported count 277/642
• PERCENT: 41.2% does not match the reported count 252/630

This is a well-designed and well-reported cluster-randomized trial with a strong scientific premise, rigorous methods, and transparent reporting. The main weakness is the lack of a clear data availability statement and code sharing, which is a common reporting gap. Minor copyedit issues (missing negative signs in confidence intervals) should be corrected.

Both reviewers independently scored all eight dimensions and agreed on all statuses, so no divergence needed reconciliation. The statistics verification component recomputed only a subset of tests (2 of 8 consistent), and the coverage note clarifies that many p-values are threshold-only and cannot be machine-verified; therefore, the statistics are not fully verified but no errors were identified. The citation check found no retracted or unresolved references.

4 major claims checked against the paper's own evidence: 2 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit.

Recomputed 2 tests: 2 consistent, 0 inconsistent; 2 via agent-written checks. 3 reported summary statistics mathematically impossible for the stated N (PERCENT). 3 printed percentages that do not match their own count.

2 integrity concerns flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites prior research on hypertension prevalence, disparities, and the effectiveness of multicomponent strategies, including SPRINT. It identifies a gap in data on implementing such strategies in resource-constrained FQHC settings. The rationale linking the premise to the study objectives is explicit, and the study directly addresses the identified gap.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with extensive prior work and a logical rationale for the study.

Evidence

direct quote[Introduction, paragraphs 1-3]

“The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that intensive antihypertensive treatment targeting a systolic blood pressure <120 mm Hg significantly reduced cardiovascular disease events and all-cause mortality, compared to a target systolic blood pressure of <140 mm Hg.”